(2021). Correction: Tisagenlecleucel infusion in patients with relapsed/refractory ALL and concurrent serious infection. BMJ Publishing Group.
Style de citation Chicago (17e éd.)Correction: Tisagenlecleucel Infusion in Patients with Relapsed/refractory ALL and Concurrent Serious Infection. BMJ Publishing Group, 2021.
Style de citation MLA (8e éd.)Correction: Tisagenlecleucel Infusion in Patients with Relapsed/refractory ALL and Concurrent Serious Infection. BMJ Publishing Group, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.